Title Zdravstvena njega bolesnika oboljelog od Hodgkinova limfoma
Title (english) Health care of a patient with Hodgkin's lymphoma
Author Danijela Kralj
Mentor Melita Sajko (mentor)
Committee member Duško Kardum (predsjednik povjerenstva)
Committee member Melita Sajko (član povjerenstva)
Committee member Valentina Novak (član povjerenstva)
Granter University North (University centre Varaždin) (Department of Nursing) Koprivnica
Defense date and country 2023-07-10, Croatia
Scientific / art field, discipline and subdiscipline BIOMEDICINE AND HEALTHCARE Clinical Medical Sciences Nursing
Abstract Hodgkinov limfom jedan je od sve učestalijih hematoloških zloćudnih bolesti s
incidencijom od oko 3 slučaja na 100 000 osoba godišnje te se upravo navedenom dijagnozom
bavi ovaj završni rad. Pregled literature pokazuje da HL ima osebujnu dobnu distribuciju s
prevalencijom ne samo u starijoj životnoj dobi, već i kod mlađih odraslih osoba, što ga čini
jednim od najčešćih karcinoma u ovoj dobnoj skupini. HL ima stopu izlječenja od 80 do 90% s
kombiniranom kemoterapijom i radioterapijom što ga ubraja među limfome s dobrom stopom
izlječenja. Novi pristupi liječenju, posebno s inhibitorima imunoloških kontrolnih točaka te
transplantacijom matičnih stanica pokazuju obećavajuće rezultate u poboljšanju izlječenja i
smanjenju nuspojava i dugotrajne toksičnosti povezane s konvencionalnom terapijom. HL dijeli
se u četiri glavna oblika: klasični HL miješane celularnosti (MCCHL), Hodgkinov limfom bogat
limfocitima (LRCHL), Klasični Hodgkinov limfom s osiromašenim limfocitima (LDCHL) te HL
s prevladavanjem nodularnih limfocita (NLPHL). Tumorske stanice koje prevladavaju u
navedenoj bolesti nazivaju se Hodgkinove i Reed-Sternbergove (HRS) stanice. Ovi oblici HL
razlikuju se u morfologiji i imunofenotipu stanica limfoma, sastavu mikrookruženja limfoma i
njihovom kliničkom ponašanju. Dok je liječenje HL-a velika priča o uspjehu i iako je HL prvi
limfoidni zloćudni tumor koji je prepoznat s prvim opisom prije više od 150 godina, njegova
biologija i patogeneza dugo su bile zagonetne. Glavni razlog tome je rijetkost tumorskih stanica
u zahvaćenim limfnim čvorovima, što je uvelike otežavalo njihovu molekularnu analizu. U
sklopu ovog rada analizirala se zdravstvena njega bolesnika oboljelih od Hodgkinova limfoma
koja predstavlja velik izazov u sestrinskoj skrbi.
Abstract (english) Hodgkin's lymphoma is one of the increasingly frequent hematological malignancies with
an incidence of about 3 cases per 100,000 people per year, and this final thesis deals with the
diagnosis mentioned above. A review of the literature shows that HL has a peculiar age
distribution with a prevalence not only in older age but also in younger adults, making it one of
the most common cancers in this age group. HL has a cure rate of 80 to 90% with combined
chemotherapy and radiotherapy, making it one of the lymphomas with a good cure rate. New
treatment approaches, particularly with immune checkpoint inhibitors and stem cell
transplantation, show promising results in improving healing and reducing side effects and longterm
toxicity associated with conventional therapy. HL is divided into four main forms: classic
mixed cellularity HL (MCCHL), lymphocyte-rich Hodgkin's lymphoma (LRCHL), classic
lymphocyte-depleted Hodgkin's lymphoma (LDCHL), and nodular lymphocyte-predominant HL
(NLPHL). Tumor cells that predominate in this disease are called Hodgkin and Reed-Sternberg
(HRS) cells. These forms of HL differ in the morphology and immunophenotype of the
lymphoma cells, the composition of the lymphoma microenvironment, and their clinical
behavior. While the treatment of HL is a great success story and although HL is the first
lymphoid malignancy to be recognized with its first description more than 150 years ago, its
biology and pathogenesis have long been enigmatic. The main reason for this is the rarity of
tumor cells in the affected lymph nodes, which greatly hampered their molecular analysis. As
part of this work, the health care of patients with Hodgkin's lymphoma, which represents a major
challenge in nursing care, was analyzed.
Keywords
Hodgkinov limfom
zdravstvena skrb
liječenje
Keywords (english)
Hodgkin's lymphoma
health care
treatment
Language croatian
URN:NBN urn:nbn:hr:122:825833
Study programme Title: Nursing Study programme type: professional Study level: undergraduate Academic / professional title: stručni/a prvostupnik/prvostupnica (baccalaureus/baccalaurea) sestrinstva (stručni/a prvostupnik/prvostupnica (baccalaureus/baccalaurea) sestrinstva)
Type of resource Text
File origin Born digital
Access conditions Open access
Terms of use
Created on 2023-07-19 13:42:42